Synthesis and biological activity of aldose reductase inhibitors with Michael acceptor substituents

Isaac O. Donkor, Yasar S. Abdel-Ghany, Peter F. Kador, Tadashi Mizoguchi, Anita Bartoszko-Malik, Duane D. Miller

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Derivatives of alrestatin (1-5) and alconil (6-8) possessing Michael acceptor substituents were synthesized as aldose reductase inhibitors. The alrestatin derivatives demonstrated enhanced aldose reductase inhibitory activity. The most potent reversible inhibitor of the series (compound 3) was 15-fold more active than alrestatin. Additionally, lipophilic analogues of alrestatin selectively inhibited rat lens aldose reductase versus rat kidney aldehyde reductase. Unlike alrestatin derivatives, alconil derivatives with similar substituents did not demonstrate significant reversible or irreversible inhibition of aldose reductase.

Original languageEnglish (US)
Pages (from-to)235-243
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume34
Issue number3
DOIs
StatePublished - Mar 1999

Keywords

  • Aldehyde reductase
  • Aldose reductase
  • Alrestatin
  • Diabetic complications
  • Michael acceptors

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Synthesis and biological activity of aldose reductase inhibitors with Michael acceptor substituents'. Together they form a unique fingerprint.

Cite this